C07D 209/40
Nitrogen atoms, not forming part of a nitro radical
Official title: Nitrogen atoms, not forming part of a nitro radical, e.g. isatin semicarbazone
C07D209/40 (Nitrogen atoms, not forming part of a nitro radical) appears on 266 US grants and 296 published applications in this corpus.
Search patents in C07D- Granted patents
- 266
- Published applications
- 296
- Assignees
- 223
- Inventors
- 1,008
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 0 | 0 |
| 1978 | 5 | 0 |
| 1979 | 3 | 0 |
| 1980 | 6 | 0 |
| 1981 | 3 | 0 |
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 2 | 0 |
| 1985 | 1 | 0 |
| 1986 | 2 | 0 |
| 1987 | 2 | 0 |
| 1988 | 3 | 0 |
| 1989 | 2 | 0 |
| 1990 | 3 | 0 |
| 1991 | 1 | 0 |
| 1992 | 3 | 0 |
| 1993 | 3 | 0 |
| 1994 | 1 | 0 |
| 1995 | 4 | 0 |
| 1996 | 4 | 0 |
| 1997 | 2 | 0 |
| 1998 | 3 | 0 |
| 1999 | 5 | 0 |
| 2000 | 5 | 0 |
| 2001 | 6 | 1 |
| 2002 | 6 | 6 |
| 2003 | 5 | 14 |
| 2004 | 5 | 15 |
| 2005 | 8 | 10 |
| 2006 | 8 | 9 |
| 2007 | 6 | 11 |
| 2008 | 8 | 15 |
| 2009 | 8 | 12 |
| 2010 | 5 | 13 |
| 2011 | 7 | 9 |
| 2012 | 10 | 9 |
| 2013 | 6 | 10 |
| 2014 | 11 | 4 |
| 2015 | 5 | 18 |
| 2016 | 6 | 13 |
| 2017 | 17 | 16 |
| 2018 | 10 | 17 |
| 2019 | 18 | 13 |
| 2020 | 9 | 14 |
| 2021 | 3 | 8 |
| 2022 | 10 | 14 |
| 2023 | 5 | 17 |
| 2024 | 8 | 13 |
| 2025 | 5 | 8 |
| 2026 | 2 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Small molecules with antibacterial activity16 Jun 2026US 12,655,101 B2New Mexico Tech University Research Park Corporation
- Isoindoline derivatives20 Jan 2026US 12,528,789 B2Sun Chemical Corporation
- Compounds and compositions for treating conditions associated with STING activity23 Dec 2025US 12,503,436 B2Novartis Pharma AG
- Pyrrolo 12.3-dipyrimidine compounds and analogues thereof2 Dec 2025US 12,485,109 B2BioCryst Pharmaceuticals, Inc.
- Methods using HDAC11 inhibitors25 Nov 2025US 12,479,807 B2Valo Health, Inc.
- Compounds for the treatment of hiv10 Sep 2026US 2026/0265194 A1Dana-Farber Cancer Institute, Inc.
- Compounds, compositions and methods of use to treat hypoparathyroidism and osteoporosis3 Sep 2026US 2026/0258007 A1Septerna, Inc.
- Novel indoline derivative and use thereof27 Aug 2026US 2026/0250247 A1Ck Regeon Inc.
- Stereogenic 3,3-disubstituted 3-amino oxindole compounds and a process for preparation thereof9 Jul 2026US 2026/0193184 A1Council of Scientific and Industrial Research
- Pannexin-1 modulators and methods of treating disorders in which pannexin-1 is implicated28 May 2026US 2026/0146041 A1Pannex Therapeutics Inc.
Most cited
By later US patents
- Substituted oxidole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors94US 6,369,086 B1SmithKline Beecham Corporation · 2002
- Inhibitors of phospholipase enzymes89US 6,828,344 B1Genetics Institute, Inc. · 2004
- Sulfonamides and their use as a medicament87US 8,088,772 B2The Genetics Company, Inc. · 2012
- 1-(4'-fluorophenyl)-3,5-substituted indoles useful in the treatment of psychic disorders and pharmaceutical compositions thereof51US 4,710,500 AH. Lundbeck A.S. · 1987
- Angiotensin converting enzyme inhibitors and their formulation and use as pharmaceuticals48US 4,748,160 AFisons Limited · 1988